Press release
Asthma Biologics Market Poised to Reach US$ 19.2 Billion, Growing at [12.5% CAGR] by 2031 - Transparency Market Research Inc.
Asthma Biologics
The global asthma biologics market was valued at US$ 6.5 billion in 2022 and is projected to grow at a CAGR of 12.5% from 2023 to 2031. By the end of 2031, the market is expected to surpass US$ 19.2 billion. The increasing adoption of targeted therapies, rising healthcare expenditure, and advancements in monoclonal antibody treatments are key factors fueling market growth.
Get Sample PDF Brochure from here: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=85819
Analyst Viewpoint
Industry experts anticipate strong growth in the asthma biologics market, driven by increasing approvals of novel biologics, expansion of research in respiratory diseases, and growing preference for biologics over traditional treatments. However, the high cost of biologic therapies and limited accessibility in developing regions may pose challenges to market expansion.
Market Demand and Key Drivers
Rising Prevalence of Asthma: Growing cases of severe and uncontrolled asthma are increasing demand for biologic treatments.
Advancements in Biologic Drug Development: New monoclonal antibodies and targeted therapies are enhancing asthma management.
Increasing Adoption of Personalized Medicine: Tailored biologic treatments based on genetic and phenotypic profiling are improving treatment efficacy.
Expanding Healthcare Investments: Government and private sector investments in respiratory disease treatment are driving market growth.
Regulatory Approvals and Pipeline Expansions: Continuous regulatory support for novel asthma biologics is fueling innovation.
Reduction in Corticosteroid Dependence: Biologic therapies offer alternatives to long-term corticosteroid use, reducing side effects and improving patient quality of life.
Recent Developments
2023, GlaxoSmithKline (GSK): Received FDA approval for an innovative biologic treatment targeting eosinophilic asthma.
2023, AstraZeneca: Expanded global clinical trials for a next-generation biologic therapy for severe asthma.
2024, Sanofi & Regeneron: Launched a new monoclonal antibody drug targeting Type 2 inflammation in asthma patients.
2024, Novartis: Announced advancements in its asthma biologic pipeline, with a focus on IL-5 inhibitors.
2024, Teva Pharmaceuticals: Developed a biosimilar asthma biologic, expected to improve market accessibility.
Key Market Players
Amgen, Inc.
AstraZeneca
F. Hoffmann-La Roche Ltd.
GSK plc
Novartis AG
Regeneron Pharmaceuticals, Inc.
Sanofi
Teva Pharmaceutical Industries Ltd.
Other Prominent Players
Visit our report to discover essential insights and analysis - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=85819
Market Trends and Opportunities
Expansion of Monoclonal Antibody Treatments: The introduction of new biologics targeting IL-4, IL-5, and IgE is driving innovation.
Increasing Focus on Type 2 Inflammation Pathway: New therapies targeting Type 2 inflammation are gaining traction in asthma management.
Growing Awareness and Diagnosis Rates: Increased awareness campaigns and diagnostic advancements are improving asthma detection and treatment rates.
Development of Biosimilars for Asthma Biologics: The emergence of biosimilars is expected to enhance affordability and market penetration.
Strategic Partnerships and Collaborations: Leading pharmaceutical companies are forming alliances to accelerate biologic drug development and distribution.
Market Segmentation
By Drug Class:
Anti-IgE Monoclonal Antibodies
Anti-IL-5 Monoclonal Antibodies
Anti-IL-4 & IL-13 Monoclonal Antibodies
Others
By Route of Administration:
Intravenous
Subcutaneous
By Distribution Channel:
Hospitals
Specialty Clinics
Retail & Online Pharmacies
Regional Analysis
North America: The largest market due to high adoption of biologic therapies, advanced healthcare infrastructure, and strong regulatory support.
Europe: Significant growth driven by increasing approvals of new biologics and rising investment in respiratory disease management.
Asia-Pacific: The fastest-growing region due to rising asthma prevalence, improving healthcare access, and growing biologic drug approvals.
Latin America & Middle East/Africa: Emerging markets with increasing healthcare spending and demand for advanced asthma treatments.
Future Market Analysis
The asthma biologics market is expected to witness robust growth, driven by continued advancements in biologic drug development, increasing patient access to targeted therapies, and expansion of precision medicine applications. As research and clinical trials progress, the introduction of next-generation biologics with improved efficacy and safety profiles will further accelerate market growth. Collaborations between pharmaceutical companies and healthcare organizations will play a crucial role in shaping the future landscape of asthma treatment.
Explore Latest Research Reports by Transparency Market Research:
Hormone Replacement Therapy Market: https://www.pharmiweb.com/press-release/2025-03-12/hormone-replacement-therapy-market-to-reach-us-388-billion-by-2034-driven-by-increasing-demand-for-menopause-and-endocrine-disorder-treatments-tm
Sexually Transmitted Diseases (STD) Diagnostics Market: https://www.pharmiweb.com/press-release/2025-03-12/sexually-transmitted-diseases-std-diagnostics-market-to-exceed-us-159-billion-by-2034-fueled-by-innovation-and-rising-awareness-tmr-insights
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact Us:
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Asthma Biologics Market Poised to Reach US$ 19.2 Billion, Growing at [12.5% CAGR] by 2031 - Transparency Market Research Inc. here
News-ID: 3932185 • Views: …
More Releases from Transparency Market Research
Silicon Capacitors Market Outlook 2023-2031: Projected Market Size, Key Growth D …
The silicon capacitors market includes critical electronic components used for storing and controlling electrical energy within circuits. These capacitors are extensively utilized in sectors such as consumer electronics, automotive, telecommunications, aerospace, and industrial automation. With the rising demand for compact, high-performance electronic devices, silicon capacitors have become essential in fulfilling the efficiency and reliability requirements of today's advanced electronic systems.
Silicon capacitors market is projected to reach a value of US$…
Logic Semiconductor Market Insights 2022-2031: Projected Market Size, Key Trends …
The logic semiconductor market has played a crucial role in supporting the global electronics industry, forming the foundation for a wide array of devices and systems across multiple sectors. Between 2022 and 2031, the market is set to experience substantial growth, driven by the rise of emerging technologies, growing demand for advanced electronic devices, and the ongoing evolution of key industry trends.
The logic semiconductor market is expected to reach a…
Global Underwater Connectors Market Forecast 2023-2031 - Market Size, Drivers, T …
The global underwater connectors market is poised for significant growth between 2023 and 2031, fueled by the increasing demand for dependable subsea communication and power transmission solutions across various industries. These connectors play a crucial role in facilitating connectivity between subsea equipment, underwater vehicles, and offshore installations, ensuring seamless data transfer, power distribution, and control signaling for enhanced operational efficiency.
Underwater connectors market will reach US$ 3.1 billion by 2031. The…
Water Analysis Instruments Market Set to Expand at CAGR of 6.8% during 2023-2031
Water analysis instruments play a critical role in evaluating water quality across diverse applications such as environmental monitoring, industrial processes, municipal water treatment, and research laboratories. These tools are used to detect contaminants, measure pH levels, and analyze chemical composition to ensure water safety and adherence to regulatory standards. The market is witnessing strong growth driven by rising demand for clean water and the enforcement of stringent environmental regulations.
The Water…
More Releases for Asthma
Asthma Treatment Market: Increase in Prevalence of Asthma and Rise in Awareness …
Transparency Market Research (TMR) has published a new report on the asthma treatment market for the forecast period of 2019–2027. According to the report, the global asthma treatment market was valued at ~US$ 25 Bn in 2018, and is projected to expand at a CAGR of ~2% from 2019 to 2027.
Read Report Overview - https://www.transparencymarketresearch.com/asthma-treatment-market.html
Overview
Asthma treatment involves two main types of medications: long-term asthma control medications and quick-relief (rescue) medications.
Asthma…
Anti-Asthma Drugs Market Factors Affecting Market Growth 2018 | Key Type of Asth …
To Track and Analyze Competitive Developments such as Joint Ventures, Strategic Alliances, Mergers and Acquisitions, New Product Developments, and Research and Developments Globally. The all things added in “Global Anti Asthma Drugs Market Research Report – Forecast to 2022” – Avail Prime Report to MRFR
Anti-Asthma Drugs Market - Overview
With the air pollution rising around the world, the number of asthma patients is also increasing. Therefore the market for the drugs…
Asthma-Pipeline Review H2 2017
ReportsWeb.com published “Asthma” from its database. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Asthma-Pipeline Review, H2 2017, provides an overview of the Asthma (Respiratory) pipeline landscape.
Asthma is a chronic disease involving the airways in the lungs. These airways, or bronchial tubes, allow…
Landmark Asthma Study Demonstrates Device Choice Determines Asthma Control
Monaghan Medical Corporation understands that for those with asthma, particularly children, choosing the device that best delivers their medication is an important consideration.
Plattsburgh, NY, USA -- Monaghan Medical Corporation understands that for those with asthma, particularly children, choosing the device that best delivers their medication is an important consideration. Research has shown that even when using the same metered-dose inhaler (MDI), not all valved holding chambers perform equally well.[1]
A landmark…
Asthma-Pipeline Review H2 2017
ReportsWeb.com published “Asthma” from its database. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Asthma-Pipeline Review, H2 2017, provides an overview of the Asthma (Respiratory) pipeline landscape.
Asthma is a chronic disease involving the airways in the lungs. These airways, or bronchial tubes, allow…
Asthma Therapeutics Market to 2020 - Personalized Treatment for Severe Asthma to …
Recent Research, a leading business intelligence provider, has released its latest research report: “Asthma Therapeutics Market to 2020 - Personalized Treatment for Severe Asthma to Drive Market Growth despite Patent Expirations.”
The asthma therapeutics market is forecast to grow marginally over the forecast period across the top eight developed nations, from $18.4 billion in 2013 to a projected value of $21.7 billion by 2020 at a Compound Annual Growth Rate (CAGR)…
